Budget Impact Analysis of Everolimus Plus Exemestane Versus Gemcitabine Plus Paclitaxel and Capecitabine Plus Docetaxel in Metastatic Breast Cancer Patients in Egypt

Value Health. 2014 Nov;17(7):A622. doi: 10.1016/j.jval.2014.08.2207. Epub 2014 Oct 26.

Authors

G Elsisi¹, E Saeed², M Elmahdawy³

Affiliations

¹ Ministry of Health, Faculty of Pharmacy Helwan University, Cairo, Egypt.
² Central Administration for Pharmaceutical Affairs, Cairo, Egypt.
³ Ministry of Health, Cairo, Egypt.

PMID: 27202191
DOI: 10.1016/j.jval.2014.08.2207

No abstract available